Corporate Actions
Aarti Pharmalabs reports minor chemical leakage incident at Tarapur Plant

24-Mar-26   14:22 Hrs IST
According to the company, a minor leakage occurred while loading dimethyl sulphate, an industrial chemical, into a tanker. The leak was promptly contained and cleared, and there was no loss of life or damage to property.

As a precautionary measure, 22 workers were admitted to a nearby hospital for observation, of whom more than half have already been discharged.

The company informed the local police station, following which a First Information Report (FIR) was registered. An investigation into the incident is currently underway, and the company said it is fully cooperating with the authorities.

Aarti Pharmalabs added that normal operations at the plant were safely restored within 24 hours of the incident.

Aarti Pharmalabs (APL) is an established, internationally recognized manufacturer of active pharmaceutical ingredients (APIs), pharmaceutical intermediates, new chemical entities (NCEs), and xanthine derivatives based in India.

The company reported a 35.2% decline in consolidated net profit to Rs 47.96 crore, despite a 19.6% decline in revenue from operations to Rs 432.27 crore in Q3 FY26 compared with Q3 FY25.

The counter advanced 2.49% to Rs 631.95 on the BSE.

Powered by Capital Market - Live News

Attention Investors: Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. || Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. || Pay 20% upfront margin of the transaction value to trade in cash market segment. || Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard. || Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.|| KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.|| No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.